3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design

被引:0
|
作者
Sisir Nandi
Manish C. Bagchi
机构
[1] Indian Institute of Chemical Biology,Structural Biology and Bioinformatics Division
来源
Molecular Diversity | 2010年 / 14卷
关键词
Murine tumors; Anilinoquinazoline derivatives; Molecular field analysis; Steric and electrostatic descriptors; Partial least squares; Binding affinity;
D O I
暂无
中图分类号
学科分类号
摘要
The present article is an attempt to formulate the three-dimensional quantitative structure–activity relationship (3D-QSAR) modeling of 4-anilinoquinazoline derivatives having promising anticancer activities inhibiting epidermal growth factor (EGFR) kinase. Molecular field analysis was applied for the generation of steric and electrostatic descriptors based on aligned structures. Partial least-squares (PLS) method was applied for QSAR model development considering training and test set approaches. The PLS models showed some interesting results in terms of internal and external predictability against EGFR kinase inhibition for such type of anilinoquinazoline derivatives. Steric and electrostatic field effects are discussed in the light of contribution plot generated. Finally, molecular docking analysis was carried out to better understand of the interactions between EGFR target and inhibitors in this series. Hydrophobic and hydrogen-bond interactions lead to identification of active binding sites of EGFR protein in the docked complex.
引用
收藏
页码:27 / 38
页数:11
相关论文
共 50 条
  • [1] 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design
    Nandi, Sisir
    Bagchi, Manish C.
    [J]. MOLECULAR DIVERSITY, 2010, 14 (01) : 27 - 38
  • [2] 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
    Assefa, H
    Kamath, S
    Buolamwini, JK
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2003, 17 (08) : 475 - 493
  • [3] 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
    Haregewein Assefa
    Shantaram Kamath
    John K. Buolamwini
    [J]. Journal of Computer-Aided Molecular Design, 2003, 17 : 475 - 493
  • [4] Molecular docking studies of the 4-anilinoquinazoline inhibitors with EGFR
    Zhu, LL
    Hou, TJ
    Chen, LR
    Xu, XJ
    [J]. ACTA CHIMICA SINICA, 2002, 60 (01) : 43 - 48
  • [5] A Rational Approach to Anticancer Drug Design: 2D and 3D-QSAR, Molecular Docking and Prediction of ADME Properties using Silico Studies of Thymidine Phosphorylase Inhibitors
    Raut, Vaibhav V. V.
    Bhandari, Shashikant V. V.
    Patil, Shital M. M.
    Sarkate, Aniket P. P.
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2023, 20 (02) : 153 - 166
  • [6] Novel 4-Anilinoquinazoline Derivatives as Potent Anticancer Agents: Design, Synthesis, Cytotoxic Activity, and Docking Study
    Moghadam, Fatemeh Azmian
    Dabirian, Sara
    Dogaheh, Mahtab Ghasemi
    Mojabi, Mohammad
    Yousefbeyk, Fatemeh
    Ghasemi, Saeed
    [J]. AUSTRALIAN JOURNAL OF CHEMISTRY, 2021, 74 (10) : 730 - 739
  • [7] Molecular docking and 3D-QSAR studies of 4-phenylpiperidine derivatives as μ-opioid agonists
    Liu, Ming
    Hu, Wenxiang
    Liu, Xiaoli
    [J]. NATURAL RESOURCES AND SUSTAINABLE DEVELOPMENT, PTS 1-3, 2012, 361-363 : 263 - +
  • [8] A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: A rational approach to anticancer drug design
    Noolvi, Malleshappa N.
    Patel, Harun M.
    [J]. JOURNAL OF SAUDI CHEMICAL SOCIETY, 2013, 17 (04) : 361 - 379
  • [9] Design and Anticancer Evaluation of Novel Norcantharidin Derivatives with 3D-QSAR studies
    Hu, Chunqi
    Wang, Guofang
    Wu, Chunlei
    Deng, Liping
    [J]. JOURNAL OF THE CHEMICAL SOCIETY OF PAKISTAN, 2017, 39 (02): : 261 - 268
  • [10] Molecular Docking and 3D-QSAR Studies on 7-azaindole Derivatives as Inhibitors of Trk A: A Strategic Design in Novel Anticancer Agents
    Aouidate, Adnane
    Ghaleb, Adib
    Ghamali, Mounir
    Chtita, Samir
    Ousaa, Abdellah
    Choukrad, M'barek
    Sbai, Abdelouahid
    Bouachrine, Mohammed
    Lakhlifi, Tahar
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2018, 15 (11) : 1211 - 1223